P.A. Leeson

647 total citations
30 papers, 154 citations indexed

About

P.A. Leeson is a scholar working on Pathology and Forensic Medicine, Organic Chemistry and Genetics. According to data from OpenAlex, P.A. Leeson has authored 30 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Organic Chemistry and 3 papers in Genetics. Recurrent topics in P.A. Leeson's work include Synthesis and biological activity (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Vitamin D Research Studies (2 papers). P.A. Leeson is often cited by papers focused on Synthesis and biological activity (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Vitamin D Research Studies (2 papers). P.A. Leeson collaborates with scholars based in United Kingdom. P.A. Leeson's co-authors include J. Castañer, Paul Fourman, M. Bayés, Jean‐Sébastien Silvestre, X Rabasseda, J. Castañer, Martín Cullell-Young, Luis H. Martín Arias, L.A. Sorbera and Mariana del Fresno and has published in prestigious journals such as The Lancet, The Journal of Laryngology & Otology and Drugs of the Future.

In The Last Decade

P.A. Leeson

28 papers receiving 133 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.A. Leeson United Kingdom	8	49	45	29	20	20	30	154
Naoya Matsumura Japan	11	75 1.5×	81 1.8×	14 0.5×	14 0.7×	34 1.7×	21	290
Meredith A. Allen United States	8	71 1.4×	62 1.4×	39 1.3×	67 3.4×	20 1.0×	16	281
Gregor Mlinšek Slovenia	10	46 0.9×	67 1.5×	37 1.3×	7 0.3×	18 0.9×	34	252
Thomas H. Williams United States	10	109 2.2×	86 1.9×	30 1.0×	68 3.4×	33 1.6×	18	335
Giorgio Segre Italy	9	66 1.3×	131 2.9×	18 0.6×	69 3.5×	32 1.6×	20	299
Teruki Hamada Japan	9	97 2.0×	126 2.8×	76 2.6×	10 0.5×	20 1.0×	18	318
Jiang Ji China	9	18 0.4×	56 1.2×	27 0.9×	25 1.3×	26 1.3×	24	278
Eric Garver United States	9	26 0.5×	40 0.9×	20 0.7×	31 1.6×	50 2.5×	10	186
A Ercoli Italy	10	38 0.8×	94 2.1×	42 1.4×	13 0.7×	22 1.1×	34	255
Steven W. Louie United States	7	37 0.8×	68 1.5×	19 0.7×	38 1.9×	76 3.8×	9	221

Countries citing papers authored by P.A. Leeson

Since Specialization

Citations

This map shows the geographic impact of P.A. Leeson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.A. Leeson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.A. Leeson more than expected).

Fields of papers citing papers by P.A. Leeson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.A. Leeson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.A. Leeson. The network helps show where P.A. Leeson may publish in the future.

Co-authorship network of co-authors of P.A. Leeson

This figure shows the co-authorship network connecting the top 25 collaborators of P.A. Leeson. A scholar is included among the top collaborators of P.A. Leeson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.A. Leeson. P.A. Leeson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Leeson, P.A., et al.. (2005). AERx-Insulin. Drugs of the Future. 30(7). 673–673. 1 indexed citations

2.

Leeson, P.A., et al.. (2005). Bicifadine. Drugs of the Future. 30(1). 7–7. 14 indexed citations

3.

Cullell-Young, Martín, M. Bayés, & P.A. Leeson. (2003). Lanthanum Carbonate. Drugs of the Future. 28(3). 224–224. 2 indexed citations

4.

Sorbera, L.A., P.A. Leeson, J. Castañer, & Mariana del Fresno. (2002). NXY-059: Treatment of ischemic stroke, free radical scavenger. Drugs of the Future. 27(3). 240–247. 1 indexed citations

5.

Leeson, P.A., et al.. (2002). Pegaptanib Sodium. Drugs of the Future. 27(9). 841–841. 2 indexed citations

6.

Leeson, P.A., et al.. (2002). Bevacizumab. Drugs of the Future. 27(7). 625–625. 5 indexed citations

7.

Castañer, J., et al.. (2002). Bay-43-9006. Drugs of the Future. 27(12). 1141–1141. 10 indexed citations

8.

Leeson, P.A., et al.. (2001). ABT-594. Drugs of the Future. 26(10). 927–927. 4 indexed citations

9.

Arias, Luis H. Martín, et al.. (2001). BMS-204352. Drugs of the Future. 26(1). 9–9. 4 indexed citations

10.

Leeson, P.A., et al.. (2001). Bimatoprost. Drugs of the Future. 26(5). 433–433. 4 indexed citations

11.

Leeson, P.A., et al.. (2000). Mitiglinide Calcium Hydrate. Drugs of the Future. 25(10). 1034–1034. 6 indexed citations

12.

Leeson, P.A., et al.. (2000). Desloratadine: Treatment of allergic rhinitis, Histamine H1 antagonist. Drugs of the Future. 25(4). 339–339. 7 indexed citations

13.

Rabasseda, X, P.A. Leeson, & J. Castañer. (1999). Arzoxifene Hydrochloride. Drugs of the Future. 24(6). 599–599. 3 indexed citations

14.

Sorbera, L.A., P.A. Leeson, & J. Castañer. (1999). Bay-38-4766. Drugs of the Future. 24(12). 1297–1297. 1 indexed citations

15.

Leeson, P.A., et al.. (1999). SDZ-RAD. Drugs of the Future. 24(1). 22–22. 1 indexed citations

16.

Leeson, P.A., et al.. (1998). Lanperisone Hydrochloride < Rec INNM >. Drugs of the Future. 23(5). 485–485. 1 indexed citations

17.

Silvestre, Jean‐Sébastien, P.A. Leeson, & J. Castañer. (1998). JTE-522. Drugs of the Future. 23(6). 598–598. 12 indexed citations

18.

Leeson, P.A., et al.. (1998). CS-834. Drugs of the Future. 23(3). 261–261.

19.

Leeson, P.A., et al.. (1997). Bay-12-8039. Drugs of the Future. 22(2). 109–109. 12 indexed citations

20.

Leeson, P.A. & Paul Fourman. (1966). INCREASED SENSITIVITY TO VITAMIN D AFTER VITAMIN-D POISONING. The Lancet. 287(7448). 1182–1185. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact